• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Thursday, April 2, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Karger Publishers strengthens its clinical decision support business

Bioengineer by Bioengineer
April 11, 2018
in Health
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Karger Publishers has acquired Health Press Ltd to strengthen its clinical decision support business.

On March 29, Karger Publishers acquired the information service Health Press Ltd, Abingdon/UK in a move to strengthen its clinical decision support business. This acquisition complements Karger's German-based activities in translating knowledge from scientific research to clinical practice. The financial terms of the deal have not been disclosed.

Health Press Ltd is an award-winning, multi-platform information service for the medical community, providing premium content to improve medical practice. Founded by Sarah Redston in 1993, Health Press has since established three brands: the medical handbook series Fast Facts, illustrated guides to medical conditions and concerns Patient Pictures, and the consumer web product http://www.embarrassingproblems.com. All three brands serve the goal of promoting health through communication with a global network of medical practitioners and patients.

"This acquisition is a perfect addition to Karger and fully supports our strategy. It provides us with the opportunity to expand our clinical decision support business to the United Kingdom, the United States, Australia, and, more generally, English-speaking audiences worldwide," says Daniel Ebneter, CEO of Karger Publishers.

Sarah Redston, the former owner of Health Press, said: "I am delighted to have found such a good home for Health Press Limited, its talented staff and its three brands. Together with Karger, we have created a match within the field of health and science publishing at its best that will facilitate finding cures, improving clinical decisions, and increasing prevention."

###

About Karger Publishers

Karger Publishers in Basel, Switzerland, is a globally active medical and scientific publishing company. Independent and family-run in the fourth generation by Vice Chairwoman & Publisher Gabriella Karger and Chairman Thomas Karger, the company is dedicated to serving the information needs of the scientific community with publications of high-quality content, covering all fields of medical science. The publication program comprises 35 new books per year and 108 peer-reviewed journals with a growing number of open access publications. Karger content is published predominantly in English, with a strong focus on basic and clinical research, and is generally available online. S. Karger AG consists of the publishing company Karger Publishers (est. 1890) and the International Subscription Agency Karger Libri (est. 1960).

Further information about Karger Publishers: http://www.karger.com

Media Contact

Cora Wirtz
[email protected]
41-613-061-271
@KargerPublisher

http://www.karger.com

Share12Tweet7Share2ShareShareShare1

Related Posts

REV-ERBα/BNIP3 Axis Reduces Pulmonary Hypertension via Mitophagy

April 2, 2026

Gomesin Cytotoxicity Driven by Glycosphingolipids, Cholesterol

April 2, 2026

Gut Microbiome’s Role in Gastric Cancer Therapy

April 2, 2026

Spike in Kava-Related Inquiries Reported by Poison Control Centers

April 2, 2026
Please login to join discussion

POPULAR NEWS

  • blank

    Revolutionary AI Model Enhances Precision in Detecting Food Contamination

    96 shares
    Share 38 Tweet 24
  • Imagine a Social Media Feed That Challenges Your Views Instead of Reinforcing Them

    1007 shares
    Share 398 Tweet 249
  • Promising Outcomes from First Clinical Trials of Gene Regulation in Epilepsy

    51 shares
    Share 20 Tweet 13
  • Popular Anti-Aging Compound Linked to Damage in Corpus Callosum, Study Finds

    44 shares
    Share 18 Tweet 11

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

REV-ERBα/BNIP3 Axis Reduces Pulmonary Hypertension via Mitophagy

Gomesin Cytotoxicity Driven by Glycosphingolipids, Cholesterol

Gut Microbiome’s Role in Gastric Cancer Therapy

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 78 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.